What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Pathology
His primary areas of investigation include Pathology, Melanoma, Dermatology, Immunology and Nevus.
His Pathology study frequently draws connections to other fields, such as Angioma.
His Melanoma research is multidisciplinary, incorporating elements of Surgery, Metastasis and Lymph node.
He combines subjects such as Sentinel lymph node and Disease with his study of Metastasis.
His Dermatology research focuses on Blue nevus and how it relates to Malignancy.
His Cutaneous melanoma research is multidisciplinary, relying on both Cancer, Breslow Thickness, Risk factor and Lymph.
His most cited work include:
- Final Version of 2009 AJCC Melanoma Staging and Classification (3479 citations)
- The Histogenesis and Biologic Behavior of Primary Human Malignant Melanomas of the Skin (1797 citations)
- Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients (816 citations)
What are the main themes of his work throughout his whole career to date?
Martin C. Mihm mainly focuses on Pathology, Melanoma, Dermatology, Immunology and Nevus.
His Pathology study frequently involves adjacent topics like Metastasis.
Martin C. Mihm interconnects Cancer, Internal medicine, Lymph node and Oncology in the investigation of issues within Melanoma.
His Dermatology research includes elements of Melanocytic nevus, Biopsy, Blue nevus and Dysplastic nevus.
His Biopsy study frequently links to related topics such as Sentinel lymph node.
As part of his studies on Immunology, Martin C. Mihm often connects relevant areas like Cancer research.
He most often published in these fields:
- Pathology (64.32%)
- Melanoma (46.40%)
- Dermatology (29.96%)
What were the highlights of his more recent work (between 2011-2021)?
- Pathology (64.32%)
- Melanoma (46.40%)
- Dermatology (29.96%)
In recent papers he was focusing on the following fields of study:
Martin C. Mihm spends much of his time researching Pathology, Melanoma, Dermatology, Nevus and Internal medicine.
His Pathology study integrates concerns from other disciplines, such as Superficial spreading melanoma and Metastasis.
His studies deal with areas such as Immune system, Immunology, Cancer and Sentinel lymph node as well as Melanoma.
His research integrates issues of Spitz nevus and Lymph node in his study of Sentinel lymph node.
He has researched Dermatology in several fields, including Melanocytic nevus, Biopsy, Blue nevus and Dysplastic nevus.
His Internal medicine study which covers Oncology that intersects with Breslow Thickness and Survival rate.
Between 2011 and 2021, his most popular works were:
- Loss of 5-Hydroxymethylcytosine Is an Epigenetic Hallmark of Melanoma (541 citations)
- Cancer classification using the Immunoscore: a worldwide task force (525 citations)
- Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma (362 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
His primary scientific interests are in Melanoma, Pathology, Dermatology, Immunology and Cancer research.
His research in Melanoma is mostly concerned with Cutaneous melanoma.
The Pathology study combines topics in areas such as Rats sprague dawley, Metastasis, Port-wine stain, Revascularization and Vascular malformation.
His study in Dermatology is interdisciplinary in nature, drawing from both Biopsy, Nevus, Spitz nevus and Medical diagnosis.
His study looks at the relationship between Immunology and fields such as Cancer, as well as how they intersect with chemical problems.
His Cancer research study incorporates themes from Carcinogenesis, Ipilimumab and Lymphocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
